Embecta Corp. (NASDAQ: EMBC) was unchanged Tuesday, as the global diabetes care company with a 100-year legacy in insulin delivery announced a new landmark publication in the Mayo Clinic Proceedings.
("embecta") (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, today announced a new ...
Strategic Expansion into Global Travel Industry. NEW YORK, NY , April 01, 2025 (GLOBE NEWSWIRE) -- Guardforce AI Co., Limited ...
In this episode of C&EN Uncovered, host Craig Bettenhausen speaks with C&EN assistant editor Laurel Oldach about the use of horseshoe crab blood in pharmaceutical endotoxin testing, the challenges of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results